Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metast...
Download
1 / 23

Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metastatic Evaluation - PowerPoint PPT Presentation


  • 252 Views
  • Uploaded on

Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metastatic Evaluation. The American Surgeon, Vol 67:p582-584, June 2001 Peyton W. Davis, Nancy D. Perrier, Lee Adler, and Edward A. Levine. Speaker: 8700021 陳修弘. Introduction.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metastatic Evaluation' - shayla


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg

Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metastatic Evaluation

The American Surgeon, Vol 67:p582-584, June 2001

Peyton W. Davis, Nancy D. Perrier, Lee Adler, and Edward A. Levine.

Speaker: 8700021 陳修弘


Introduction l.jpg

Introduction Tomography Scanning Obtained for Metastatic Evaluation


Positron emission tomography pet i l.jpg
Positron Emission Tomography (PET) ~ I Tomography Scanning Obtained for Metastatic Evaluation

  • Tracer: [18F]fluorodeoxyglucose (FDG)

  • Cells with higher glucose requirements


Positron emission tomography pet ii l.jpg
Positron Emission Tomography (PET) ~ II Tomography Scanning Obtained for Metastatic Evaluation

  • Evaluation of patients at risk of having metastatic disease

    • Staging of malignant melanoma

    • Therapeutic management of patients with recurrent colorectal carcinoma

    • Identification of esophageal and gastric carcinoma

    • Evaluating patients with suspicious thyroid nodules


The purpose of this study l.jpg
The Purpose of this Study Tomography Scanning Obtained for Metastatic Evaluation

  • To review for cases in which an abnormality was identified by PET in the region or the thyroid


Methods l.jpg

Methods Tomography Scanning Obtained for Metastatic Evaluation


Methods i l.jpg
Methods ~ I Tomography Scanning Obtained for Metastatic Evaluation

  • Patients were for scanning as part of a metastatic workup

  • PET scans or the chest or torso for known or suspected extrathyroidal malignancy

    • 1284 consecutive patients at Wake Forest University Baptist Medical Center

    • ECAT 951 scanner (CTI, Knoxville, TN)

    • Between April 1998 and May 2000


Methods ii l.jpg
Methods ~ II Tomography Scanning Obtained for Metastatic Evaluation

  • PET procedure

    • Patients received a 4-minute-per-bed position transmission scan

    • Followed by intravenous administration of 15- to 20-mCi FDG

    • After a 45-min to one-hr delay 7-minute-per-bed position emission imaging was performed


Methods iii l.jpg
Methods ~ III Tomography Scanning Obtained for Metastatic Evaluation

  • The emission scan and the transmission scan were reconstructed and reviewed on a workstation in all three orthogonal planes

  • The peak activity per cubic centimeter in suspicious areas was corrected for

    • the dose administered

    • lean body weight

    • radioactive decay

    • blood glucose level

      to produce a standardized uptake value (SUV).


Methods iv l.jpg
Methods ~ IV Tomography Scanning Obtained for Metastatic Evaluation

  • Four patients with a suspicious area in the thyroid region who were followed up with a fine-needle aspiration (FNA) biopsy under ultrasound guidance.

    • Two malignant melanoma

    • One gastric adenocarcinoma

    • One colon adenocarcinoma


Methods v l.jpg
Methods ~ V Tomography Scanning Obtained for Metastatic Evaluation

  • They subsequently underwent surgical resection and appropriate adjuvant therapies for their original malignancy

  • At a later date all cases underwent a definitive resection for the thyroid FNA findings.


Results l.jpg

Results Tomography Scanning Obtained for Metastatic Evaluation


Results i l.jpg
Results ~ I Tomography Scanning Obtained for Metastatic Evaluation


Results ii l.jpg
Results ~ II Tomography Scanning Obtained for Metastatic Evaluation


Results iii l.jpg
Results ~ III Tomography Scanning Obtained for Metastatic Evaluation

  • PET scan results:

    • P1: No other abnormalities

    • P2: Hilum of the right lung

    • P3: Gastroesophageal junction and left lung

    • P4: Suspicious area in the liver

    • P5: Rectal and thyroid uptake only


Results iv l.jpg
Results ~ IV Tomography Scanning Obtained for Metastatic Evaluation

  • FNA results

    • Revealed papillary carcinoma of the thyroid in the five cases

    • Case five underwent surgery based on uncertainty of a negative ultrasound guided FNA

    • Histology: supported the diagnosis of papillary carcinoma without any evidence of metastatic disease from the original malignancy.

    • No patients has suffered a recurrence of the thyroid lesion.


Discussion l.jpg

Discussion Tomography Scanning Obtained for Metastatic Evaluation


Discussion i l.jpg
Discussion ~ I Tomography Scanning Obtained for Metastatic Evaluation

  • Current methods of detecting thyroid malignancy and recurrence

    • Sonography

    • 131I

    • 123I whole-body scan

    • Serum thyroglobulin levels

    • Thallium-201 scintigraphy


Discussion ii l.jpg
Discussion ~ II Tomography Scanning Obtained for Metastatic Evaluation

  • PET V.S these other modalities

    • Superior to scintigraphy in the identification of benign versus malignant thyroid tumors

    • In one study of six patienst with positive PET and negative 131I scans five had positive histology for carcinoma

    • PET has a sensitivity of 94% and specificity of 95% fir metastatic disease in patients with negative 131I scan


Discussion iii l.jpg
Discussion ~ III Tomography Scanning Obtained for Metastatic Evaluation

  • Other studies have supported the usefulness of PET in evaluating metastatic thyroid disease in patients with negative thallium scans.

  • FDG PET can stratify these patients into high- and low-risk subsets

  • FDG PET has definite usefulness in treating patients with known thyroid malignancy or metastases


Discussion iv l.jpg
Discussion ~ IV Tomography Scanning Obtained for Metastatic Evaluation

  • In this report, authors address cases in which PET identified an area of occult thyroid carcinoma

  • These scans were useful in the management of these patients in that metastatic disease was not the cause of their PET abnormality.


Conclusion l.jpg
Conclusion Tomography Scanning Obtained for Metastatic Evaluation

  • These incidental findings suggest

    • The diagnosis of a primary thyroid malignancy should be entertained for abnormalities of the thyroid observed on PET

    • Support a potential role for FDG-PET as a component of the evaluation of primary thyroid malignancies


Slide23 l.jpg

Thanks! Tomography Scanning Obtained for Metastatic Evaluation


ad